Envafolimab Injection

DRUG3 trials

Sponsors

Peking University Third Hospital, Northern Jiangsu People's Hospital, Nanjing First Hospital, Nanjing Medical University

Conditions

Cervical CancerGastrointestinal NeoplasmsNSCLC

Phase 2

A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer

Northern Jiangsu People's HospitalNSCLC

Start: 2023-10-18End: 2025-10-18Target: 16Updated: 2023-10-31

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

RecruitingNCT06301828

Nanjing First Hospital, Nanjing Medical UniversityGastrointestinal Neoplasms

Start: 2024-02-21End: 2026-02-21Target: 16Updated: 2024-03-08

Unknown Phase

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Not yet recruitingNCT05879796

Peking University Third HospitalCervical Cancer

Start: 2023-05-16End: 2026-05-16Target: 30Updated: 2023-05-30